Sign In
Buy BIO
$301.90
-2.46 (-0.81%)
At Close: Jul 20, 2026
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that the United States Court of Appeals for the Federal Circuit to
Zurcher Kantonalbank Zurich Cantonalbank Grows Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
07:04am, Tuesday, 04'th Aug 2020
Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 1.6% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned
Wells Fargo & Co Increases Bio-Rad Laboratories (NYSE:BIO) Price Target to $590.00
06:18am, Tuesday, 04'th Aug 2020
Bio-Rad Laboratories (NYSE:BIO) had its target price raised by Wells Fargo & Co from $525.00 to $590.00 in a report issued on Friday, The Fly reports. The brokerage currently has an overweight rating
The Global Biotechnology Reagents Market will grow by USD 37.87 bn during 2020-2024
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by Sumitomo Mitsui Trust Holdings Inc.
08:10am, Monday, 03'rd Aug 2020
Sumitomo Mitsui Trust Holdings Inc. boosted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 0.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exch
The Global DNA Sequencing Market will grow by USD 12.5 bn during 2020-2024
Nissay Asset Management Corp Japan ADV Has $1.06 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
07:42am, Sunday, 02'nd Aug 2020
Nissay Asset Management Corp Japan ADV raised its position in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 11.6% during the second quarter, according to the company in its most recent disclosure with the
Bio-Rad Laboratories (NYSE:BIO) Reaches New 52-Week High on Earnings Beat
09:52am, Saturday, 01'st Aug 2020
Bio-Rad Laboratories, Inc. (NYSE:BIO) shares reached a new 52-week high on Thursday following a stronger than expected earnings report. The stock traded as high as $539.00 and last traded at $534.74,
Bio-Rad Laboratories Inc (BIO) (BIO.B) Q2 2020 Earnings Call Transcript
12:33am, Saturday, 01'st Aug 2020
Ladies and gentlemen, thank you for standing by, and welcome to the Q2 2020 Bio-Rad Laboratories, Inc. Earnings Conference Call. Before we begin our review, I would like to caution everyone that we w
Bio-Rad (BIO) Q2 Earnings Beat Estimates, Gross Margin Rises
02:36pm, Friday, 31'st Jul 2020
Bio-Rad's (BIO) second-quarter 2020 results reflect strong performance by the Life Sciences segment, boosted by coronavirus-led increased testing demand.
The Daily Biotech Pulse: Sanofi-GSK Land $2.1B Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche
12:00am, Friday, 31'st Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 30)
Achieve Life Sciences Inc (NASDAQ: ACHV)
Annexon Inc (NASDAQ: ANNX) (IPOed July 24)
Atossa Therapeutics...
Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Surpass Estimates
09:45pm, Thursday, 30'th Jul 2020
Bio-Rad (BIO) delivered earnings and revenue surprises of 23.85% and 1.91%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Bio-Rad Reports Second-Quarter 2020 Financial Results
08:15pm, Thursday, 30'th Jul 2020
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP)
Annexon...
Medical Products Stock Earnings on Jul 30: BAX, SYK & More
01:16pm, Wednesday, 29'th Jul 2020
Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.
